Literature DB >> 15718823

Transscleral permeability of fluorescent-labeled antibiotics.

James C Kao1, Dayle H Geroski, Henry F Edelhauser.   

Abstract

PURPOSE: To determine the in vitro transscleral permeability of antibiotics for posterior segment infection.
METHODS: Scleral sections from moist chamber-stored human globes were mounted in a 2-compartment perfusion chamber. Fluorescent-labeled vancomycin, polymyxin B, or penicillin G was added to the episcleral surface, while the choroidal side was slowly perfused with balanced salt solution (Alcon Laboratories, Inc., Ft. Worth, TX). The perfusate was collected and fluorescence was measured using a fluorometer. From the measurements, permeability (Ktrans) was calculated. Photomicrographs were taken with a fluorescent microscope to evaluate tissue absorption.
RESULTS: The Ktrans values (cm/s, mean +/- standard error) were 6.66 +/- 1.46 x 10(-7) for vancomycin, 3.90 +/- 0.59 x 10(-7) for polymyxin B, and 1.89 +/- 0.21 x 10(-6) for penicillin G. The percent of antibiotic that diffused across the sclera from the donor chamber in 24 hours was 20.6 +/- 4.2 for vancomycin, 12.6 +/- 2.0% for polymyxin B, and 50.8 +/- 4.8% for penicillin G.
CONCLUSIONS: This study shows that human sclera is more permeable to lower molecular weight, water-soluble penicillin G than to vancomycin or polymyxin B. The data suggests that a local, noninvasive, transscleral drug-delivery method may be reasonable for treating intraocular infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15718823     DOI: 10.1089/jop.2005.21.1

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  4 in total

1.  Effect of menthol on ocular drug delivery.

Authors:  Xiaolin Xu; Nannan Yu; Zhengzhong Bai; Yanbin Xun; Di Jin; Zhijian Li; Hao Cui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-05-20       Impact factor: 3.117

2.  Trans-scleral permeability of Oregon green 488.

Authors:  Sung Jin Lee; Stephen J Kim; Esther S Kim; Dayle H Geroski; Bernard E McCarey; Henry F Edelhauser
Journal:  J Ocul Pharmacol Ther       Date:  2008-12       Impact factor: 2.671

Review 3.  Vascular endothelial growth factor in eye disease.

Authors:  J S Penn; A Madan; R B Caldwell; M Bartoli; R W Caldwell; M E Hartnett
Journal:  Prog Retin Eye Res       Date:  2008-05-28       Impact factor: 21.198

4.  Research on the comparison of the demethylvancomycin's diffusion-deposition characteristics in the ocular solid tissues of sustained subtenon drug delivery with subconjunctival injection.

Authors:  Yi-Qin Duan; Ye-Zhen Yang; Xue-Tao Huang; Ding Lin
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.